InsiderTrades

Form 4 for TDOC Teladoc Health, Inc.

Accepted 2022-11-01 00:00:00 ET · period of report 2022-10-28 · accession 0001415889-22-010933 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-11-01 2022-10-28 TDOC Geshuri Arnnon CHRO M - OptEx — +1,060 77.2K +1% —
D 2022-11-01 2022-10-31 TDOC Geshuri Arnnon CHRO S - Sale+OE $29.56 -527 76.7K -0.7% -$15.6K
D 2022-11-01 2022-10-28 TDOC Geshuri Arnnon CHRO M - OptEx $0.00 -1,060 1,061 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-10-28 M A 1,060 — 77,242 D — — (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
2 Common Common Stock 2022-10-31 S D 527 $29.56 76,715 D — — (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit award.
3 Derivative Restricted Stock Units 2022-10-28 M D 1,060 $0.00 1,061 D — · — to — 1,060 Common Stock (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F3) On October 30, 2020, the reporting person was granted 3,181 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.